Nantahala Capital Management - Q3 2018 holdings

$3.72 Billion is the total value of Nantahala Capital Management's 119 reported holdings in Q3 2018. The portfolio turnover from Q2 2018 to Q3 2018 was 29.2% .

 Value Shares↓ Weighting
IWM BuyISHARES TRput$741,620,000
+126.4%
4,400,000
+120.0%
19.96%
+50.5%
IYR NewISHARES TRput$240,060,0003,000,000
+100.0%
6.46%
EXAS BuyEXACT SCIENCES CORPput$235,087,000
+110.4%
2,978,800
+59.4%
6.33%
+39.8%
SGMS BuySCIENTIFIC GAMES CORPcall$164,503,000
+47.0%
6,476,500
+184.5%
4.43%
-2.3%
FCAU BuyFIAT CHRYSLER AUTOMOBILES Ncall$139,555,000
+2.6%
7,970,000
+10.7%
3.76%
-31.8%
CDXS  CODEXIS INC$114,561,000
+19.1%
6,679,9540.0%3.08%
-20.8%
HCA BuyHCA HEALTHCARE INCput$97,384,000
+374.6%
700,000
+250.0%
2.62%
+215.3%
XBI BuySPDR SERIES TRUSTput$95,870,000
+83.1%
1,000,000
+81.8%
2.58%
+21.7%
WRLD BuyWORLD ACCEP CORP DEL$83,187,000
+21.5%
727,412
+18.0%
2.24%
-19.3%
AABA  ALTABA INC$79,816,000
-7.0%
1,171,6910.0%2.15%
-38.2%
RH BuyRHcall$78,096,000
+61.5%
596,100
+72.2%
2.10%
+7.4%
ARQL SellARQULE INC$68,497,000
+1.3%
12,101,879
-1.0%
1.84%
-32.6%
QURE BuyUNIQURE NV$68,503,000
+3.2%
1,882,471
+7.2%
1.84%
-31.4%
QURE  UNIQURE NVcall$65,502,000
-3.7%
1,800,0000.0%1.76%
-36.0%
SODA SellSODASTREAM INTERNATIONAL LTDcall$63,041,000
+64.2%
440,600
-2.1%
1.70%
+9.1%
LXFR  LUXFER HOLDINGS PLC$61,514,000
+33.0%
2,645,7490.0%1.66%
-11.6%
THC BuyTENET HEALTHCARE CORP$60,005,000
+11.4%
2,108,403
+31.4%
1.62%
-25.9%
GDEN BuyGOLDEN ENTMT INC$57,775,000
+9.4%
2,406,298
+22.9%
1.56%
-27.3%
IBB NewISHARES TRput$48,776,000400,000
+100.0%
1.31%
XELA  EXELA TECHNOLOGIES INC$47,504,000
+50.1%
6,662,5820.0%1.28%
-0.2%
QADA BuyQAD INCcl a$47,186,000
+37.0%
832,927
+21.3%
1.27%
-8.9%
CURO BuyCURO GROUP HLDGS CORP$44,647,000
+45.5%
1,476,902
+20.1%
1.20%
-3.3%
CASH BuyMETA FINL GROUP INC$44,591,000
-4.6%
539,516
+12.4%
1.20%
-36.6%
SPY BuySPDR S&P 500 ETF TRcall$43,608,000
+60.7%
150,000
+50.0%
1.17%
+6.8%
CVNA NewCARVANA COcl a$43,473,000735,700
+100.0%
1.17%
AKBA BuyAKEBIA THERAPEUTICS INC$41,715,000
-7.6%
4,724,211
+4.4%
1.12%
-38.6%
DXPE BuyDXP ENTERPRISES INC NEW$38,749,000
+31.1%
967,028
+25.0%
1.04%
-12.9%
NTRI BuyNUTRI SYS INC NEWput$37,050,000
+20.3%
1,000,000
+25.0%
1.00%
-20.0%
THC BuyTENET HEALTHCARE CORPcall$36,287,000
+96.5%
1,275,000
+131.8%
0.98%
+30.5%
AFI BuyARMSTRONG FLOORING INC$32,155,000
+38.6%
1,776,513
+7.5%
0.86%
-8.0%
PRTY BuyPARTY CITY HOLDCO INC$32,098,000
-1.5%
2,368,883
+10.8%
0.86%
-34.5%
DLB SellDOLBY LABORATORIES INC$30,922,000
-19.8%
441,932
-29.3%
0.83%
-46.7%
HTZGQ BuyHERTZ GLOBAL HLDGS INCcall$29,394,000
+139.5%
1,800,000
+125.0%
0.79%
+59.2%
SODA SellSODASTREAM INTERNATIONAL LTD$29,312,000
+40.4%
204,865
-16.3%
0.79%
-6.6%
ONDK BuyON DECK CAP INC$28,767,000
+9.6%
3,800,145
+1.3%
0.77%
-27.2%
CZR NewCAESARS ENTMT CORPcall$25,625,0002,500,000
+100.0%
0.69%
ENT  GLOBAL EAGLE ENTMT INC$25,387,000
+11.9%
9,002,6290.0%0.68%
-25.6%
CRHM BuyCRH MEDICAL CORP$24,513,000
+59.2%
6,155,826
+25.1%
0.66%
+5.9%
AGLE BuyAEGLEA BIOTHERAPEUTICS INC$24,186,000
+3.3%
2,527,260
+14.2%
0.65%
-31.3%
TBBK BuyBANCORP INC DEL$23,295,000
+30.1%
2,429,139
+41.9%
0.63%
-13.5%
IMXI NewINTERNATIONAL MNY EXPRESS IN$21,404,0001,780,698
+100.0%
0.58%
ACER BuyACER THERAPEUTICS INC$21,322,000
+294.5%
691,388
+176.3%
0.57%
+162.1%
HRB  BLOCK H & R INCput$20,600,000
+13.0%
800,0000.0%0.55%
-24.9%
BPI SellBRIDGEPOINT ED INC$19,630,000
+41.4%
1,932,134
-9.1%
0.53%
-6.0%
ADT  ADT INCcall$18,780,000
+8.6%
2,000,0000.0%0.50%
-27.9%
NewFALCON MINERALS CORP$16,925,0001,538,608
+100.0%
0.46%
SIGA SellSIGA TECHNOLOGIES INC$16,181,000
+10.4%
2,348,457
-4.8%
0.44%
-26.6%
SGYPQ SellSYNERGY PHARMACEUTICALS DEL$14,048,000
-30.3%
8,263,335
-28.6%
0.38%
-53.7%
GLMD BuyGALMED PHARMACEUTICALS LTD$11,389,000
+29.1%
838,674
+13.2%
0.31%
-14.3%
ORM BuyOWENS RLTY MTG INC$11,304,000
+1.7%
669,273
+0.4%
0.30%
-32.4%
VIVE  VIVEVE MED INC$10,581,000
-1.5%
3,948,1320.0%0.28%
-34.5%
RH NewRH$10,131,00077,328
+100.0%
0.27%
GM  GENERAL MTRS COput$10,101,000
-14.5%
300,0000.0%0.27%
-43.2%
FTDCQ BuyFTD COS INC$9,759,000
-4.3%
3,710,763
+68.8%
0.26%
-36.3%
TLYS  TILLYS INCcl a$9,704,000
+25.1%
512,1030.0%0.26%
-16.9%
DHX BuyDHI GROUP INC$9,633,000
-0.5%
4,587,341
+11.3%
0.26%
-33.9%
PCG NewPG&E CORP$9,432,000205,000
+100.0%
0.25%
GTTN NewGTT COMMUNICATIONS INC$9,186,000211,658
+100.0%
0.25%
SSKN BuySTRATA SKIN SCIENCES INC$9,058,000
+112.6%
2,558,891
+23.1%
0.24%
+41.0%
JYNT BuyJOINT CORP$8,761,000
+100.3%
1,024,721
+91.6%
0.24%
+33.3%
APEN BuyAPOLLO ENDOSURGERY INC$8,547,000
+88.4%
1,191,985
+83.4%
0.23%
+25.0%
CCXI BuyCHEMOCENTRYX INC$8,132,000
+0.4%
643,338
+4.6%
0.22%
-33.2%
CUE BuyCUE BIOPHARMA INC$7,721,000
+53.7%
853,098
+101.4%
0.21%
+2.5%
AKBA  AKEBIA THERAPEUTICS INCcall$7,515,000
-11.5%
851,0000.0%0.20%
-41.3%
SGMS SellSCIENTIFIC GAMES CORP$7,242,000
-71.9%
285,100
-45.7%
0.20%
-81.3%
FLWS NewFLWS/1-800 FLOWERScl a$6,868,000582,051
+100.0%
0.18%
IOVA SellIOVANCE BIOTHERAPEUTICS INC$6,769,000
-35.9%
601,710
-27.1%
0.18%
-57.5%
F  FORD MTR CO DELput$6,475,000
-16.4%
700,0000.0%0.17%
-44.6%
GAIA BuyGAIA INC NEWcl a$6,437,000
-8.7%
417,996
+20.1%
0.17%
-39.3%
SHOS  SEARS HOMETOWN & OUTLET STOR$6,366,000
+39.3%
2,176,2510.0%0.17%
-7.6%
EMMS  EMMIS COMMUNICATIONS CORP$5,716,000
-1.1%
1,092,9510.0%0.15%
-34.2%
LINC BuyLINCOLN EDL SVCS CORP$5,462,000
+45.3%
2,416,805
+11.9%
0.15%
-3.3%
RRR  RED ROCK RESORTS INCput$5,330,000
-20.4%
200,0000.0%0.14%
-47.2%
NATR BuyNATURES SUNSHINE PRODUCTS IN$5,047,000
-6.4%
576,807
+0.0%
0.14%
-37.6%
ESTA NewESTABLISHMENT LABS HLDGS INC$4,820,000200,000
+100.0%
0.13%
BDSI NewBIODELIVERY SCIENCES INTL IN$4,667,0001,666,667
+100.0%
0.13%
MFCB BuyMFC BANCORP LTD$4,603,000
+15.3%
754,632
+11.9%
0.12%
-23.5%
TA  TRAVELCENTERS AMER LLC$4,329,000
+62.9%
759,4010.0%0.12%
+7.4%
RFL  RAFAEL HLDGS INC$3,705,000
-8.6%
441,0920.0%0.10%
-39.0%
DVD  DOVER MOTORSPORTS INC$3,710,000
-4.5%
1,725,7890.0%0.10%
-36.3%
PIRS NewPIERIS PHARMACEUTICALS INC$3,561,000635,845
+100.0%
0.10%
ELVT SellELEVATE CREDIT INC$3,575,000
-62.9%
443,491
-61.0%
0.10%
-75.4%
DDE SellDOVER DOWNS GAMING & ENTMT I$3,298,000
-1.8%
1,161,233
-38.4%
0.09%
-34.6%
ASCMA BuyASCENT CAP GROUP INC$3,176,000
-31.3%
1,794,260
+9.1%
0.08%
-54.5%
RLGT  RADIANT LOGISTICS INC$3,105,000
+51.2%
525,3000.0%0.08%
+1.2%
KIRK  KIRKLANDS INCput$3,027,000
-13.3%
300,0000.0%0.08%
-42.6%
RMBL NewRUMBLEON INCcl b$2,728,000260,343
+100.0%
0.07%
RRTS BuyROADRUNNER TRNSN SVCS HLDG I$2,465,000
-53.8%
2,948,930
+15.6%
0.07%
-69.4%
PAR NewPAR TECHNOLOGY CORP$2,455,000110,504
+100.0%
0.07%
STRM  STREAMLINE HEALTH SOLUTIONS$2,121,000
-17.5%
1,760,2970.0%0.06%
-45.2%
NewFALCON MINERALS CORP*w exp 07/21/202$1,494,000878,022
+100.0%
0.04%
SHLDQ  SEARS HLDGS CORPput$968,000
-59.2%
1,000,0000.0%0.03%
-72.9%
SHLDQ  SEARS HLDGS CORPcall$968,000
-59.2%
1,000,0000.0%0.03%
-72.9%
SHLDQ SellSEARS HLDGS CORP$764,000
-69.4%
789,201
-25.0%
0.02%
-79.2%
PTIE  PAIN THERAPEUTICS INC$654,000
-50.9%
647,0530.0%0.02%
-66.7%
IMXIW NewINTERNATIONAL MNY EXPRESS IN*w exp 01/19/202$587,000249,999
+100.0%
0.02%
RBCAA  REPUBLIC BANCORP KYcl a$340,000
+1.8%
7,3710.0%0.01%
-35.7%
FNTEW ExitFINTECH ACQUISITION CORP II*w exp 01/19/202$0-249,999
-100.0%
-0.02%
TWMC ExitTRANS WORLD ENTMT CORP$0-722,647
-100.0%
-0.02%
TISI ExitTEAM INC$0-60,400
-100.0%
-0.06%
TAXA ExitLIBERTY TAX INCcl a$0-808,239
-100.0%
-0.26%
OSPRU ExitOSPREY ENERGY ACQUISITION COunit 07/21/2022$0-1,000,000
-100.0%
-0.44%
FNTE ExitFINTECH ACQUISITION CORP II$0-1,204,498
-100.0%
-0.49%
WRLD ExitWORLD ACCEP CORP DELcall$0-155,100
-100.0%
-0.70%
JMBA ExitJAMBA INC$0-1,834,835
-100.0%
-0.79%
SPY ExitSPDR S&P 500 ETF TRput$0-350,000
-100.0%
-3.84%
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2018-11-14
Signatures

The EDGAR filing(s) were signed by:

About Nantahala Capital Management

Nantahala Capital Management is a hedge fund that was founded in 2004 by Wil Harkey. The firm is headquartered in Connecticut and has additional offices in New York and North Carolina. Nantahala Capital Management primarily invests in the technology, healthcare, and consumer sectors. The firm has a long-term investment approach and seeks to identify undervalued companies with strong growth potential.

Wil Harkey serves as the CEO and Chief Investment Officer of Nantahala Capital Management. He has over 20 years of experience in the finance industry and previously worked at Goldman Sachs and Maverick Capital. In addition to Harkey, the firm's leadership team includes COO and General Counsel, David Kozak, and CFO, Michael Kozak.

Nantahala Capital Management has a strong track record of generating positive returns for its investors. The firm's flagship fund, the Nantahala Fund, has delivered an annualized return of over 20% since its inception in 2006. The firm's success can be attributed to its disciplined investment approach and focus on long-term value creation.

Overall, Nantahala Capital Management is a well-respected hedge fund with a talented leadership team and a strong track record of performance. However, as with any investment, it is important for investors to conduct their own due diligence and carefully consider the risks before investing in the firm's funds.

It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
ISHARES TR42Q3 202327.2%
CODEXIS INC42Q3 20233.9%
PATHWARD FINANCIAL INC35Q3 20236.3%
SCIENTIFIC GAMES CORP34Q3 20225.3%
DOVER MOTORSPORTS INC34Q3 20210.5%
GOLDEN ENTMT INC33Q3 20232.1%
QAD INC32Q3 20212.6%
SCIENTIFIC GAMES CORP31Q4 20217.7%
DOLBY LABORATORIES INC31Q4 20205.6%
LINCOLN EDL SVCS CORP31Q4 20210.7%

View Nantahala Capital Management's complete holdings history.

Latest significant ownerships (13-D/G)
Nantahala Capital Management Q3 2018 significant holdings filed using form 13D/G when ownership exceeds 5% of a company's total stock issue.
FiledShares Percentage
AYTU BIOPHARMA, INCJune 16, 20231,086,81219.7%
Acer Therapeutics Inc.February 14, 20231,226,1917.5%
Aeglea BioTherapeutics, Inc.February 14, 20234,611,3027.5%
AKUMIN INC.February 14, 20232,206,9602.5%
ALTA EQUIPMENT GROUP INC.February 14, 20231,188,9853.7%
Apollo Endosurgery, Inc.February 14, 20234,056,6279.9%
Autolus Therapeutics plcFebruary 14, 20237,782,0184.7%
Bioventus Inc.February 14, 20233,168,5745.1%
CATALYST BIOSCIENCES, INC.February 14, 2023438,0551.4%
Drive Shack Inc.February 14, 20236,500,0007.0%

View Nantahala Capital Management's complete significant-ownership history.

Latest filings
TypeFiled
42024-03-21
42024-03-15
SC 13G2024-03-11
13F-HR/A2024-02-15
13F-HR2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14

View Nantahala Capital Management's complete filings history.

Compare quarters

Export Nantahala Capital Management's holdings